This contrasted with ibrutinib-treated CLL platelets in which no phosphorylation of Btk Y223 was detected in response to IV.3-xl, CRP-xl and TRAP-6 (Figure 5D). Here, BTK is linked to B-cell chronic lymphocytic leukemia.